Systemic Candida infection in burn patients: A case-control study of management patterns and outcomes

Surgical Infections

Volumn 3, Issue 4, 2002, Pages 367-374

  Cochran, Amalia ^a   Morris, Stephen E ^a   Edelman, Linda S ^a   Saffle, Jeffrey R ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; FLUCONAZOLE; IMIPENEM; SULFADIAZINE; VANCOMYCIN;

ABDOMINAL SURGERY; ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; ARTIFICIAL SKIN; BODY SURFACE; CANDIDIASIS; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FUNGUS CULTURE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MORTALITY; OPPORTUNISTIC INFECTION; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN AUTOGRAFT; SURVIVAL RATE; THERMAL INJURY; THICKNESS; TRACHEOSTOMY;

EID: 0036928923     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/109629602762539580     Document Type: Article

References (18)

1. Becker WK Jr, McManus AT, Kim SH, et al. Fungal burn wound infections: A 10-year experience. Arch Surg 1991;126:44-48.
2. Ekenna O, Sheretz RJ, Bingham W. Natural history of bloodstream infections in a burn patient population: The importance of candidemia. Am J Infect Control 1993;21:189-195.
3. Still JM, Belcher K, Law EJ. Management of candida septicaemia in a regional burn unit. Burns 1995;21: 594-596.
4. Wey SB, Mori M, Pfaller MA, et al. Hospital-acquired candidemia: The attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-2645.
5. Giamarellou H, Antoniadou A. Epidemiology, diagnosis, and therapy of fungal infections in surgery. Infect Control Hosp Epidemiol 1996;17:558-564.
6. Cornwell ED, Belzberg H, Berne TV, et al. The pattern of fungal infections in critically ill surgical patients. Am Surg 1995;61:847-850.
7. Wright WL, Wenzel RP. Nosocomial Candida: Epidemiology, transmission, and prevention. Infect Dis Clin North Am 1997;11:411-425.
8. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Am J Med 1987;147: 2117-2120.
9. Spebar MJ, Pruitt BA Jr. Candidiasis in the burned patient. J Trauma 1981;21:237-239.
10. MacMillian BG, Law EJ, Holder IA. Experience with Candida infections in the burn patient. Arch Surg 1972;104:509-514.
11. Prasad JK, Feller I, Thompson PD. A ten-year review of Candida sepsis and mortality in burn patients. Surgery 1987;101:213-216.
12. Dean AD, Burchard KW. Surgical perspective on invasive Candida infections. World J Surg 1998;22:127-134.
13. Ryan CM, Schoenfeld DA, Thorpe WP, et al. Objective estimates of the probability of death from burn injuries. New Engl J Med 1998;338:362-366.
14. Mueller MJ, Pegg SP, Rule MR. Determinants of death following burn injury. Br J Surg 2001;88:583-587.
15. Desai M, Rutan RL, Heggers JP, et al. Candida infection with and without nystatin prophylaxis. Arch Surg 1992;127:159-162.
16. Desai M, Herndon D, Abston S. Candida infection in massively burned patients. J Trauma 1987;27:1186-1188.
17. Edwards JE Jr. Should all patients with candidemia be treated with antifungal agents? Clin Infect Dis 1992;15:422-423.
18. Gauto A, Law EJ, Holder IA, et al. Experience with amphotericin-B in the treatment of systemic candidiasis in burn patients. Am J Surg 1977;133:174-178.